Abstract:Glioblastoma is the most common malignant brain tumor in adults and is characterized by extensive proliferation and the diffused invasion of tumor cells. Due to the intricate signaling pathways involved in glioma progression, more effective targeted therapies and prognostic biomarkers in clinical practice are required. The suppression of proto-oncogene function or recovery of tumor suppressor gene function remains one of the primary approaches in gene therapy. The close association between the abnormal expression or mutation of microRNA (miRNA) and the tumorigenesis, progression and staging in glioma have been demonstrated previously. However, the expression pattern and specific role of microRNA-130b (miR-130b) in the tumor occurrence and progression of glioma are unclear. In the present study, quantitative polymerase chain reaction was performed to determine the expression level of miR-130b in 30 brain glioma patients and 3 glioma cell lines. An miR-130b inhibitor was transfected into U87 cells to downregulate the expression of miR-130b, and assessments of cell proliferation, cell cycle, apoptosis, cell invasion and migration in vitro and nude mouse tumorigenicity in vivo were conducted. Western blotting and luciferase reporter gene technology were used to verify the downstream target gene of miR-130b, namely phosphatase and tensin homolog (PTEN). The results demonstrated that miR-130b expression was increased in glioma tissues and cell lines in comparison with non-glioma tissues or cells. The downregulated expression of miR-130b inhibited the proliferation and invasion of glioma cells, induced apoptosis of the cells in vitro and inhibited their tumorigenicity in vivo. Western blotting and luciferase reporter assays demonstrated that the PTEN gene is a direct target of miR-130b. Western blotting revealed that the miR-130b inhibitor upregulated the expression of PTEN, inhibited AKT pathway activation, upregulated the tumor suppressor gene p27, and suppressed cyclin D1, matrix metalloproteinase 2 and 9 expression. These results suggest that the miR-130b inhibitor suppressed glioma cell proliferation and invasion via the PTEN/AKT pathway. Therefore, miR-130b is suggested to be an effective therapeutic target for glioma.

MiR-130b functions as a tumor promoter in glioma via regulation of ERK/MAPK pathway.

Suppression Of Microrna-130b Inhibits Glioma Cell Proliferation And Invasion, And Induces Apoptosis By Pten/Akt Signaling

Mir-130B Regulates the Proliferation, Invasion and Apoptosis of Glioma Cells Via Targeting of CYLD.

MicroRNA-130b Promotes Cell Proliferation and Invasion by Inhibiting Peroxisome Proliferator-Activated Receptor-Γ in Human Glioma Cells

MicroRNA-1301 Inhibits Proliferation of Human Glioma Cells by Directly Targeting N-Ras.

Microrna-138 Modulates Glioma Cell Growth, Apoptosis And Invasion Through The Suppression Of The Akt/Mtor Signalling Pathway By Targeting Creb1

Mir-138-5p Suppresses Glioblastoma Cell Viability and Leads to Cell Cycle Arrest by Targeting Cyclin D3.

Mir-130A-3p Promotes Cell Proliferation and Invasion by Targeting Estrogen Receptor Α and Androgen Receptor in Cervical Cancer.

Involvement of Microrna-1297, a New Regulator of HMGA1, in the Regulation of Glioma Cell Growth in Vivo and in Vitro.

MiR-130b Inhibits Proliferation and Induces Apoptosis of Gastric Cancer Cells Via CYLD

MiR-130 Exerts Tumor Suppressive Function on the Tumorigenesis of Human Non-Small Cell Lung Cancer by Targeting PTEN.

miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3

MiR-1306-5p Predicts Favorable Prognosis and Inhibits Proliferation, Migration, and Invasion of Colorectal Cancer Cells Via PI3K/AKT/mTOR Pathway

[The Expression and Clinopathological Significance of Mir-130B in Human Hepatocellular Carcinoma].

Mir-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells

MiR-130b Plays an Oncogenic Role by Repressing PTEN Expression in Esophageal Squamous Cell Carcinoma Cells

MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling

miR-129-5p targets Wnt5a to block PKC/ERK/NF-κB and JNK pathways in glioblastoma

Upregulation of microRNA‐133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway

miR-193a-3p Promotes the Invasion, Migration, and Mesenchymal Transition in Glioma through Regulating BTRC

miR-130a can predict response to temozolomide in patients with glioblastoma multiforme, independently of O6-methylguanine-DNA methyltransferase